
Radiance Research
GLOW 70mg
70mg
GLOW is a co-lyophilized research blend that assembles three complementary tissue-remodeling references into a single vial: GHK-Cu (copper…
$130.00



Front
Radiance
$80.00
Strength · 100mg
GHK-Cu is a copper-binding tripeptide researched for its role in models of tissue-remodeling and skin-matrix signaling.
Research Notice
For laboratory research use only. Not for human consumption.
The Dossier
GHK-Cu is a naturally occurring tripeptide-copper complex — glycyl-L-histidyl-L-lysine chelated to a copper(II) ion — first isolated from human plasma in 1973. Its endogenous levels are documented to decline with age, and the bound copper gives the complex its characteristic blue-purple color.
It is a signature reference in the radiance category, studied for its role in models of tissue-remodeling and skin-matrix signaling.
GHK-Cu is characterized as a copper-delivery vehicle that 'redox-silences' the bound ion — supplying copper to enzymes such as lysyl oxidase and superoxide dismutase while limiting oxidative toxicity.
Gene-expression analyses describe it as a broad modulator, shifting expression across thousands of genes, with reported engagement of Nrf2/Keap1 antioxidant signaling and NF-κB/p38 MAPK modulation, alongside stimulation of extracellular-matrix synthesis.
Store the lyophilized powder at −20°C, protected from moisture. It is characterized as stable across a mildly acidic-to-neutral pH range and dissociates outside it; hold reconstituted solution cold.
Related Research

Radiance Research
70mg
GLOW is a co-lyophilized research blend that assembles three complementary tissue-remodeling references into a single vial: GHK-Cu (copper…
$130.00

Radiance Research
80mg
KLOW extends the three-peptide GLOW stack with a fourth reference — KPV — pairing GHK-Cu, BPC-157, and TB-500 with the anti-inflammatory…
$155.00
The Source Concierge
Welcome to The Source. How may we assist you?
Replies within 24 hours — usually much sooner.